Deutsche Bank Ag\ Supernus Pharmaceuticals, Inc. Call Options Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	BUY	$26.37 - $34.22 $5,906 - $7,665	224 Added 96.97%	455 $13,000
Q3 2021 Nov 04, 2021	SELL	$23.54 - $31.39 $141 - $188	-6 Reduced 2.53%	231 $6,000
Q2 2021 Aug 11, 2021	BUY	$26.72 - $33.19 $988 - $1,228	37 Added 18.5%	237 $7,000
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $4,040 - $5,010	200 New	200 $4,000

279

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.01B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.